New drug candidate reverses obesity in mice by transforming liver metabolism

FHS
May 2, 2024
3:11 am

A mitochondrial transcription inhibitor (IMT) shifted metabolism in high-fat diet mice toward fatty acid oxidation, leading to weight loss, reduced liver fat, and improved glucose tolerance.

Scientists weigh in on RFK Jr. as HHS secretary

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. The schedule at my YMCA recently changed

November 15, 2024

Astraveus wins €10.4m French grant to advance CGT manufacturing – Pharmaceutical Technology

Lakhesys platform uses single-use microfluidic bioprocessors that mimic organ perfusion, thereby, accelerating the molecular exchanges needed to produce therapeutic agents. Image Credit: metamorworks / Shutterstock.

October 24, 2023

EPA Imposes New Limit on Medical Sterilization Chemical, Citing Cancer Risk

The Environmental Protection Agency (EPA) issued a final rule on Thursday that aims to markedly reduce cancer risks for those living near commercial sterilization facilities

March 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.